Bremelanotide Acetate

CCCCC (NC (C) =O) C (=O) NC1CC (=O) NCCCCC (NC (=O) C (CC2=C[NH]C3=CC=CC=C23) NC (=O) C (CCCN=C (N) N) NC (=O) C (CC4=CC=CC=C4) NC (=O) C (CC5=CN=C[NH]5) NC1=O) C (O) =O.CC (O) =O

Bremelanotide Acetate (PT-141 Acetate) is a melanocortin receptor (MCR) agonist recently approved in the USA for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked distress or interpersonal difficulty.